NCT05010759 - Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

July 28, 2023

Study Completion Date

July 28, 2023

Conditions

Prostate Cancer

Interventions

DEVICE

NanoTherm Ablation

Iron nanoparticles are instilled into the prostate cancer lesion and then the particles are heated using a magnetic field and this heating ablates the prostate cancer lesion.

Trial Locations (4)

33615

Florida Urology Partners, Tampa

78229

MagForce - San Antonio, San Antonio

78759

Urology Austin, Austin

98105

MagForce USA, Seattle